Last updated on February 2020

A Study to Evaluate the Safety and Efficacy of CRN00808 for the Treatment of Acromegaly

Brief description of study

An open label exploratory study designed to evaluate the safety, efficacy, and pharmacokinetics of CRN00808 (an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with acromegaly that are treated with somatostatin analogue (SSA) based treatment regimens.

Clinical Study Identifier: NCT03789656

Find a site near you

Start Over

Johns Hopkins University

Baltimore, MD United States
  Connect »

Ohio State University

Columbus, OH United States
  Connect »

University of Michigan

Ann Arbor, MI United States
  Connect »

UCLA Gonda Diabetes Center

Los Angeles, CA United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »